體外毒性測試市場：按類型、最終用戶和地區分類

In Vitro Toxicity Testing Market, By Type, By End User, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年體外毒性測試市場規模預估為114.2億美元，預計2033年將達280.4億美元。預計2026年至2033年，該市場將以13.7%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	114.2億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	13.70%	2033年市場規模預測：	280.4億美元

本研究旨在尋找傳統動物毒性試驗的替代方案，例如體外毒性試驗，並輔以電腦模擬和化學模擬試驗程序。代謝、藥物動力學和生物分析方面的研究可藉助體外毒性試驗服務。建立體外毒性評估工具，提供系統和數據，以支持系統生物學和生理建模等領域電腦建模工具的開發，是實現這一目標的關鍵要素。由於科學有效性、高效性、成本效益和倫理合理性等諸多因素，利用人類細胞和類器官的體外技術在化學毒性評估中變得越來越普遍。

市場動態

市場主要參與者正專注於研發活動，預計這將推動市場在不久的將來成長。例如，2022年6月21日，經合組織測試指南計畫國家協調員工作小組第33次會議（於2022年4月在奧地利舉行）核准了修訂後的魚類細胞株系急性毒性測試指南，該指南由經合組織動物保護國際理事會（ICAPO）發布。大量研究表明，當按照經合組織測試指南進行測試時，該測試方法能夠有效預測多種化學物質對魚類的急性毒性。因此，人們認為將此測試方法納入魚類急性毒性評估的證據權重和綜合測試與評估方法（IATA）中，可以顯著地取代魚類急性毒性測試。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球體外毒性測試市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球體外毒性測試市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球體外毒性測試市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

概述
北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

Bio-Rad Laboratories, Inc.
Cyprotex
Covance Inc.
LifeNet Health LifeSciences
Creative Bioarray
Charles River Laboratories
Intertek Group plc
LGC Limited
SGS Societe Generale de Surveillance SA
Preferred Cell Systems
Microbac Laboratories, Inc.
Eurofins Discovery
Creative Biolabs
LAUS GmbH
Vimta Labs Ltd.

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI3855

In Vitro Toxicity Testing Market is estimated to be valued at USD 11.42 Bn in 2026 and is expected to reach USD 28.04 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 11.42 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	13.70%	2033 Value Projection:	USD 28.04 Bn

The research activities are conducted to find alternatives to conventional animal-based toxicity testing such as in vitro toxicology assays thatare complemented by in silico and in chemico testing procedures. The metabolic, toxicokinetic, and bioanalytical research is supported by the in vitro toxicity testing services. The establishment of tools for in vitro toxicity assessment, which offers test systems and data required for the development of computer modelling tools for topics like system biology and physiologically based modelling, is a crucial part of this aim. A human cell and organoid-based in vitro technique is becoming increasingly popular for chemical toxicity assessment for a variety of factors including scientific relevance, effectiveness, affordability, and moral propriety.

Market Dynamics

Major players in the market are focused on the research and development activities, and thu,s it is expected to drive the market growth in near future. For instance, on June 21, 2022, a revised test guideline for the fish cell line acute toxicity assay was approved at the 33rd Meeting of the OECD Working Group of the National Coordinators, Austria for the Test Guidelines Programme in April 2022, and it had been published by the International Council on Animal Protection in OECD Programmes (ICAPO). Numerous studies have demonstrated how effectively the assay can forecast acute toxicity to fish for a wide range of chemicals when carried out in compliance with OECD test guidelines. Therefore, by including this assay into a weight of evidence or integrated approach to testing and assessment (IATA) for acute fish toxicity assessment, it has the potential to replace acute fish toxicity testing in a significant way.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global in vitro toxicity testing market based on the following parameters,company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Cyprotex, Covance Inc., LifeNet Health LifeSciences , Creative Bioarray, Charles River Laboratories, Intertek Group plc, LGC Limited, SGS Societe Generale de Surveillance SA, Preferred Cell Systems, Microbac Laboratories, Inc., Eurofins Discovery, Creative Biolabs, LAUS GmbH, and Vimta Labs Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global in vitro toxicity testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in vitro toxicity testing market

Market Segmentation

Global In Vitro Toxicity Testing Market, By Type (Revenue, USD Bn, 2021 - 2033)
Absorption
Toxic Substances
Dose
Global In Vitro Toxicity Testing Market, By End User (Revenue, USD Bn, 2021 - 2033)
Cosmetics Industry
Pharmaceutical Industry
Food Industry
Chemicals Industry
Global In Vitro Toxicity Testing Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Global In Vitro Toxicity Testing Market - Key Players
Bio-Rad Laboratories, Inc.
Cyprotex
Covance Inc.
LifeNet Health LifeSciences
Creative Bioarray
Charles River Laboratories
Intertek Group plc
LGC Limited
SGS Societe Generale de Surveillance SA
Preferred Cell Systems
Microbac Laboratories, Inc.
Eurofins Discovery
Creative Biolabs
LAUS GmbH
Vimta Labs Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global In Vitro Toxicity Testing Market, By Type, 2021-2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Absorption
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Toxic Substances
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global In Vitro Toxicity Testing Market, By End User, 2021-2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cosmetics Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pharmaceutical Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Food Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Chemicals Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global In Vitro Toxicity Testing Market, By Region, 2021-2033, (USD Bn)

Overview
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User,2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country ,2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cyprotex
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Covance Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LifeNet Health LifeSciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Creative Bioarray
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Intertek Group plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LGC Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SGS Societe Generale de Surveillance SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Preferred Cell Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Microbac Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eurofins Discovery
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Creative Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LAUS GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vimta Labs Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies